Compare CW & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CW | DGX |
|---|---|---|
| Founded | 1929 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.3B | 20.5B |
| IPO Year | N/A | 1996 |
| Metric | CW | DGX |
|---|---|---|
| Price | $659.69 | $182.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $582.50 | $196.69 |
| AVG Volume (30 Days) | 209.5K | ★ 956.1K |
| Earning Date | 02-11-2026 | 02-10-2026 |
| Dividend Yield | 0.15% | ★ 1.75% |
| EPS Growth | ★ 15.99 | 14.49 |
| EPS | ★ 12.27 | 8.51 |
| Revenue | $3,375,704,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $13.58 | $12.37 |
| Revenue Next Year | $7.28 | $3.54 |
| P/E Ratio | $52.93 | ★ $21.44 |
| Revenue Growth | 9.51 | ★ 13.74 |
| 52 Week Low | $266.88 | $153.99 |
| 52 Week High | $669.98 | $197.55 |
| Indicator | CW | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 68.97 | 53.52 |
| Support Level | $641.55 | $179.73 |
| Resistance Level | $667.82 | $191.07 |
| Average True Range (ATR) | 19.31 | 3.83 |
| MACD | 2.22 | 0.31 |
| Stochastic Oscillator | 89.38 | 55.87 |
Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.